NYSE: GKOSGlaukos Corp Stock Ownership - Who owns Glaukos?
Insider buying vs selling
Have Glaukos Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark J. Foley | Director | 2025-02-26 | 25,000 | $32.00 | $800.00kBuy |
| Mark J. Foley | Director | 2025-02-26 | 20,687 | $120.72 | $2.50MSell |
| Mark J. Foley | Director | 2025-02-26 | 15,000 | $24.69 | $370.35kBuy |
| Tomas Navratil | CHIEF DEVELOPMENT OFFICER | 2025-02-14 | 3,416 | $147.14 | $502.63kSell |
| Tomas Navratil | CHIEF DEVELOPMENT OFFICER | 2025-01-06 | 1,185 | $149.68 | $177.37kSell |
| Thomas William Burns | CHAIRMAN CEO | 2024-12-31 | 549 | $151.16 | $82.99kSell |
| Tomas Navratil | CHIEF DEVELOPMENT OFFICER | 2024-12-31 | 255 | $151.16 | $38.55kSell |
| Tomas Navratil | CHIEF DEVELOPMENT OFFICER | 2024-12-20 | 484 | $138.93 | $67.24kSell |
| Thomas William Burns | CHAIRMAN CEO | 2024-12-20 | 1,098 | $145.14 | $159.36kSell |
| Tomas Navratil | CHIEF DEVELOPMENT OFFICER | 2024-12-20 | 509 | $145.14 | $73.88kSell |
GKOS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GKOS insiders and whales buy or sell their stock.
GKOS Shareholders
What type of owners hold Glaukos Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.55% | 8,797,278 | $898.99M | Institution |
| Fmr LLC | 10.80% | 6,111,756 | $624.56M | Institution |
| Vanguard Group Inc | 10.56% | 5,974,971 | $610.58M | Institution |
| Montreux Equity Partners IV LP 1 | 5.96% | 3,371,218 | $344.50M | Insider |
| William J. Phd Link | 5.65% | 3,194,531 | $326.45M | Insider |
| Versant Ventures I LLC | 5.55% | 3,136,727 | $320.54M | Insider |
| Meritech Capital Associates III LLC | 5.35% | 3,026,678 | $309.30M | Insider |
| Paul S. Madera | 5.35% | 3,026,678 | $309.30M | Insider |
| Interwest Management Partners IX LLC | 4.60% | 2,603,362 | $266.04M | Insider |
| Frazier Healthcare V LP | 4.60% | 2,603,362 | $266.04M | Insider |
GKOS vs Medical Device Stocks
Glaukos Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.